-transparent.png){kind=logo}
[3H]nafenopin, a known inducer of liver peroxisomal enzymes, was shown to bind to a specific, saturable pool of binding sites in cytosols from rat liver and kidney cortex. Tissue levels of this binding protein (liver greater than kidney cortex; not detectable in myocardium, skeletal muscle) were seen to correlate with the ability of nafenopin to induce peroxisomal enzymes in these organs. Clofibrate and ciprofibrate, which are structurally similar to nafenopin, competitively blocked the specific binding of [3H]nafenopin. Phenobarbital, a non-inducer of peroxisomes, and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid and 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio(N-beta-hydroxyethyl)acetamide, which are structurally unrelated peroxisome proliferators, did not complete for the specific [3H]nafenopin binding sites. The [3H]nafenopin binding protein is proposed as a mediator of the drug-induced increase in peroxisomes and associated peroxisomal enzymes.
N D Lalwani, and
W E Fahl, and
J K Reddy
December 1995,
Xenobiotica; the fate of foreign compounds in biological systems,
N D Lalwani, and
W E Fahl, and
J K Reddy
May 1973,
Biochemical and biophysical research communications,
N D Lalwani, and
W E Fahl, and
J K Reddy
September 1985,
Carcinogenesis,
N D Lalwani, and
W E Fahl, and
J K Reddy
April 1976,
Cancer research,
N D Lalwani, and
W E Fahl, and
J K Reddy
January 1983,
Human toxicology,
N D Lalwani, and
W E Fahl, and
J K Reddy
August 1987,
Proceedings of the National Academy of Sciences of the United States of America,
N D Lalwani, and
W E Fahl, and
J K Reddy
November 1988,
Xenobiotica; the fate of foreign compounds in biological systems,
N D Lalwani, and
W E Fahl, and
J K Reddy
July 1978,
Archives internationales de pharmacodynamie et de therapie,
N D Lalwani, and
W E Fahl, and
J K Reddy
August 1977,
Biochemical and biophysical research communications,
N D Lalwani, and
W E Fahl, and
J K Reddy
April 1977,
Virchows Archiv. B, Cell pathology,
